I am still long STSI but have some real concerns. I am basically giving the company until end of October to deliver some significant news (this includes publishing of results in major medical journal). It has been way too long for additional news or at least leaks to come from research community specific to Anatabloc usefulness in Thyroid treatment, etc. The company reported earlier this year that study was finalized...doctors, researchers at some point would be negligent in not sharing (or someone leaking) results when they are "slam dunk" positive. My guess is that it is not so "slam dunk" which is one of the reasons for further testing and delay. Also, what other (Long) folks seem to reference are quotes, conferences, etc. from a year ago or older...no new news or reports. The lack of discussion specific to Anatabloc developments are concerning...all we have are anectdotal reports from users....which I don't discount, but unless sales volumes growing exponentially, doesn't carry the day (and they are not).
I continue to take the product due to hope that it is providing some good preventive help to my health...although I wouldn't claim miraculous results, I think it does help with soreness, stamina, etc. Is securing necessary patents what is holding things up?...hard to believe STSI would not have struck some deal with other pharma for prescription version yet.
The only thing I take some comfort in is the ridiculousness of the "shorts" positioning, etc. They do make me feel that evil is working against STSI...which to me validates that something there (with STSI and Anatabloc) must be awfully good. Would love to hear more supporting evidence to make me feel good as a Long.
Don't laugh. The longs are losing their tails. Please have some compassion for these losers. They just need to stop drinking STAR Kool-Aid because this quarter will be bad as usual. Probably worse!
"The company reported earlier this year that study was finalized...doctors, researchers at some point would be negligent in not sharing (or someone leaking) results when they are "slam dunk" positive. My guess is that it is not so "slam dunk" which is one of the reasons for further testing and delay. Also, what other (Long) folks seem to reference are quotes, conferences, etc. from a year ago or older...no new news or reports. The lack of discussion specific to Anatabloc developments are concerning."
RE "negligent", the condition for a journal to do "peer review" is that the material must not have been published elsewhere. THAT is what journals LIVE on ... first publication (thus readership, thus money to support their efforts). "Reasearchers" "leaking" would desttroy their own chance for recognition of their work. What has been said already dances on the fence line of that border.
RE "no news or reports", "lack of discussion specific to Anatabloc" is status quo because of the regulatory environment for SUPPLEMENTS. The company CANNOT make public statements that can be seen by the public as an indication that Anatabloc "treats or cures" ANY disease ... UNTIL and unless (1) verified (peer review, for example ... point made above) clinical trials are done per THAT disease, and (2) FDA subsequently agrees to/allows a proposed claim.
The company has come dangerously close to troubling the FDA to try to "allay" concerns such as yours. That in part has caused things like "Feuerstein", etc. ... so they apparently have had to apparently adopt a "strictly by the book" stance for all of this year so far (since the Jan revelations about "prelim" results), and I personally hope they continue that from here on out. It just doesn't pay.
So YOUR "problem" is not recognizing the restrictive milieu in which Star must operate at this time. It is a bit convoluted, but why not ask a question about the matter rather than assuming and "promoting" "problems"?
Izof, very much appreciate your response. And your points are very valid. Would you not agree though, that there would be some expectation that the news on the Thyroid study would certainly make sense to be published in conjuntion with the Thyroid convention in October? If the news is so captivating, doesn't an assembly of key doctors make sense to make something that has already been peer reviewed public? If not, I would say this borders on outrageous...unless researchers and the medical community are more concerned about winning statues than patient health!